GPNMB is an endogenous type I transmembrane glycoprotein, first described in melanoma biology, that is elevated in multiple neurodegenerative conditions, including Alzheimer’s disease [63], amyotrophic lateral sclerosis [64], and PD [65]. Here, GPNMB is linked to Parkinson disease.